Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Pharmacokinetic and Cardiovascular Effects of Propofol With Respect to Pharmacogenetics in the Pakistani Population.

NCT05383534 is registered in ClinicalTrials.gov with Riphah International University as lead sponsor.

NCT NCT05383534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Pharmacokinetic and Cardiovascular Effects of Propofol With Respect to Pharmacogenetics in the Pakistani Population.
Lead sponsor
Riphah International University
Phase
Observational
Overall status
Completed
Start date
January 6, 2020
Completion date
April 14, 2022
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer